381 related articles for article (PubMed ID: 3068448)
1. [Immunological changes in common vitiligo].
Vignale R; Paciel J; Calandria L
Med Cutan Ibero Lat Am; 1988; 16(4):343-7. PubMed ID: 3068448
[TBL] [Abstract][Full Text] [Related]
2. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
Lin X; Tian H; Xianmin M
Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
[TBL] [Abstract][Full Text] [Related]
3. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
Höfs T
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
[TBL] [Abstract][Full Text] [Related]
4. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
Claudy AL; Rouchouse B
Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
[TBL] [Abstract][Full Text] [Related]
6. An immunohistological study of cutaneous lymphocytes in vitiligo.
Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell subset imbalance in patients with vitiligo and in their apparently healthy first-degree relatives.
D'Amelio R; Frati C; Fattorossi A; Aiuti F
Ann Allergy; 1990 Aug; 65(2):143-5. PubMed ID: 1974400
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
10. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
[TBL] [Abstract][Full Text] [Related]
11. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site.
van den Wijngaard R; Wankowicz-Kalinska A; Le Poole C; Tigges B; Westerhof W; Das P
Lab Invest; 2000 Aug; 80(8):1299-309. PubMed ID: 10950121
[TBL] [Abstract][Full Text] [Related]
12. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of Langerhans cells activation and immune cells infiltration in progressive nonsegmental vitiligo.
Itoi S; Tanemura A; Kotobuki Y; Wataya-Kaneda M; Tsuruta D; Ishii M; Katayama I
J Dermatol Sci; 2014 Jan; 73(1):83-5. PubMed ID: 24120285
[No Abstract] [Full Text] [Related]
14. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
Chen JP; Li HP; Jin SH; Zhang JT; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
[TBL] [Abstract][Full Text] [Related]
15. [T and B lymphocytes in the ontogenetic development of man].
Smogorzewska E; Kunicka A; Siwińska-Gołebiowska H; Chazan B
Probl Med Wieku Rozwoj; 1981; 10():21-9. PubMed ID: 6984186
[TBL] [Abstract][Full Text] [Related]
16. Erythema dyschromicum perstans and vitiligo.
Naik NS
Dermatol Online J; 2003 Oct; 9(4):25. PubMed ID: 14594598
[TBL] [Abstract][Full Text] [Related]
17. Physiopathology and genetics of vitiligo.
Passeron T; Ortonne JP
J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of peripheral blood lymphocytes in patients with vitiligo.
Sheneef A; Ezz-El DR; Mahmoud TM
Egypt J Immunol; 2012; 19(1):31-8. PubMed ID: 23888549
[TBL] [Abstract][Full Text] [Related]
19. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons.
Blauvelt A; Clerici M; Lucey DR; Steinberg SM; Yarchoan R; Walker R; Shearer GM; Katz SI
J Immunol; 1995 Apr; 154(7):3506-15. PubMed ID: 7897231
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
Luiten RM; Kueter EW; Mooi W; Gallee MP; Rankin EM; Gerritsen WR; Clift SM; Nooijen WJ; Weder P; van de Kasteele WF; Sein J; van den Berk PC; Nieweg OE; Berns AM; Spits H; de Gast GC
J Clin Oncol; 2005 Dec; 23(35):8978-91. PubMed ID: 16260696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
